Journal of Medicinal Chemistry · 2003 · 85 citations · 27 references
MedicineMedicinal ChemistryPharmacologyAnesthesiaGeneral AnesthesiaMolecular PharmacologyAnesthetic Drug PharmacologyAnesthetic PharmacologyGeneral Anesthetic AgentsIon Channel PharmacologyLigand BindingAnesthetic Effects On Neurophysiological SignalsAnesthetic Mechanisms Of ActionEtomidate PharmacologyGeneral Anesthetic PharmacologyLigand-gated ChannelsLigand-gated Ion Channel PharmacologyLigand-gated Ion Channels
To locate general anesthetic binding sites on ligand-gated ion channels, a diazirine derivative of the potent intravenous anesthetic, R-(+)-etomidate (2-ethyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate), has been synthesized and characterized. R-(+)-Azietomidate [2-(3-methyl-3H-diaziren-3-yl)ethyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate] anesthetizes tadpoles with an EC(50) of 2.2 microM, identical to that of R-(+)-etomidate. At this concentration both agents equally enhanced GABA-induced currents and decreased binding of the caged-convulsant [(35)S]TBPS to GABA(A) receptors. In all of the above actions R-(+)-azietomidate is about an order of magnitude more potent than S-(-)-azietomidate, an enantioselectivity comparable to etomidate's. R-(+)-Azietomidate also inhibits acetylcholine-induced currents in nicotinic acetylcholine receptors, with about twice the potency of the parent compound. [(3)H]Azietomidate photoincorporated into Torpedo nicotinic acetylcholine receptor-rich membranes. Desensitization decreased photoincorporation into the delta-subunit and increased that into the alpha-subunit. The latter increase was confined to a proteolytic fragment containing the first three transmembrane segments. Thus, R-(+)-azietomidate is a potent stereoselective general anesthetic and an effective photolabel.
27
Sites of alcohol and volatile anaesthetic action on GABAA and glycine receptors
S. John Mihic, Qing Ye, Marilee J. Wick et al. · Nature · 1997 · 1.2K citations
Medicine, Neuroscience, Pharmacology +14